◆ 会议时间：2024年7月25-28日
◆ 会议地点：中国 香港

◆ 会议简介：

2024年第23届亚洲临床药学大会(ACCP2024)将于2024年7月25-28日在中国香港举行。亚洲临床药学大会(ACCP)包括为期3天的科学主旨演讲和大会报告，同时将举行专题研讨会、口头和海报摘要介绍，大会议题将涉及药学实践和药学科学相关领域；预计将有1500名本地代表与海外代表参加本次会议。

亚洲临床药学大会(ACCP)是一项旨在促进亚洲临床药学实践、教育和研究卓越发展的年度活动，是亚洲临床药学领域的重大事件。亚洲临床药学大会(ACCP)原为东亚发展临床药学实践和临床药学教育会议（EACDCPPE），首届会议于1997年在美国召开，第二届EACDCPPE于1999年在上海举行，2003年在日本召开的第三届会议更名为亚洲临床药学大会；2005年在马来西亚举行的第五届ACCP会议决定将会议改为每年举行一次。

The 23rd Asian Conference on Clinical Pharmacy - ACCP 2024

Date:
July 25-28, 2024

Venue:
Hong Kong Convention and Exhibition Centre
Hong Kong, China

摘要征文投稿：

Abstract Submission Information

Abstract submission deadline is 18:00 (GMT+8) on 15 March 2024 (Friday).

点此提交摘要>>>Submit Abstract>>>

General Information on Abstract Submission

You are invited to submit abstracts for either oral or e-poster presentation at the Conference. Please read the following guidelines before submission:

• Abstracts related to any one of the following categories will be considered: Clinical Practice, Education and Research
• There is a limit of one submission per presenting author.
• Expenses associated with the submission and presentation of the abstract is the responsibility of the presenters.
• The presenting author must complete the online Abstract Submission Application Form. Abstract submission by fax or post will NOT be accepted.
• Abstract submission deadline is 18:00 (GMT+8) on 15 March 2024 (Friday).
• Notification of acceptance will be sent to the corresponding authors by 15 April 2024 (Monday) with the instructions for oral presentation or e-poster preparation.
  1. Shortlisted presenters for oral presentations will be invited to give an 8-minute presentation at the Conference.
  2. Shortlisted presenters for e-poster presentations will be invited to produce their digital poster(s) for display at the Conference.
• The presenting author is required to register on or before 30 April 2024 (Tuesday) to confirm his / her participation in the oral / e-poster presentation.
• Research that has been published or presented at any national or international meeting prior to this conference is discouraged.
• Accepted abstracts will be published as submitted and distributed at the Conference. Changes to abstracts will not be accepted after the submission deadline.
• The Conference reserves the right to make minor editorial changes on the abstracts.
• If you are unable to upload your abstract file or wish to make any changes or amendments to your abstract file, please contact the ACCP 2024 Secretariat via email at abstract@accp2024.org. Please do NOT re-submit your abstract.

Guidelines for the Preparation of Abstract

• Title of abstract: capitalize the first letter of each noun and in bold at the top of the abstract. Avoid using abbreviations in the title.
• Author list: Type name(s) of author(s) with initials first, e.g. First/Middle initial(s), Surname; underline` the name of the presenting author.
• Affiliation list: Institution, Department, City, State/Province, Country
• Content: The abstract should consist of the following contents: Background, Objectives, Methods, Results, Conclusions, Keyword, Research site and Contact address. However, it is not necessary to organize the abstract under different headings.
• The abstract, excluding title and author and affiliation lists, should be no more than 300 words.
• Abstract should be typed single-line spacing using 12-point font of Times New Roman and saved in MS Word format.
• Abstract submissions and presentations should be in English.
• Standard abbreviations and generic drug names should be used.

Dear Friends and Colleagues,

On behalf of the Organizing Committee of the 23rd Asian Conference on Clinical Pharmacy (the "ACCP 2024"), I am excited to inform you that this Annual Regional Conference will be held on 25 – 28 July 2024 in Hong Kong at the Hong Kong Convention and Exhibition Centre. The International Society for Pharmacoeconomics and Outcomes Research (Hong Kong Chapter) is the host of the Conference this time.

The Conference will focus on various aspects of healthcare management in the Greater Bay Area, Asia and the globe, even with an expansion from the profession of pharmacy to an Interprofessional collaboration. With the theme of the Conference, "Interprofessional Collaboration for Better & Cost-effective Outcomes: From Greater Bay Area (GBA) to the Globe", the Conference aims to provide a forum for exchange of views and perspectives on the development of research, education and clinical services amongst academics, pharmacists, health economists, government officials, policy makers and pharmaceutical industry. I hope that it will also open up channels of communication amongst these experts. We expect to have more than 1,000 participants coming from around the world with majority from Asian countries, meeting together at this annual conference to share and exchange their expertise and local experience.

In addition to the plenary sessions in which eminent local, Asian, and international experts will speak, there will also be opportunities for investigators to present the results of their researches at the poster presentation sessions. Apart from these core sessions, there will be tours for health care facilities visit, various pre-conference workshops in relation to Immunization Certificate Training, Big Data Analysis, Health Economics and Interprofessional Education. In addition, there will be a social programme of Fellowship Night Gala Dinner on 26 July 2024.

In order to make this conference to be a successful one, your participation and support is crucial to the success of our meeting. I am sure the conference will be a rewarding experience for you. We are looking forward to welcoming you at the conference.

Yours sincerely,

Professor Vivian Lee
Chairman, Organizing Committee
ACCP 2024

注册费：

* To receive the early-bird discount, the registration form received must be postmarked on or before 30 April 2024.

◆ 参会对象：药剂师，医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。